...
首页> 外文期刊>BMJ Open >Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study
【24h】

Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study

机译:评估拔牙后出血发生率,以比较接受和不接受华法林治疗的患者:一项横断面,多中心,观察性研究

获取原文
           

摘要

Objectives We investigated incidence and risk factors for postextraction bleeding in patients receiving warfarin and those not receiving anticoagulation therapy. Design Cross-sectional, multicentre, observational study. Setting 26 hospitals where an oral surgeon is available. Participants Data on 2817 teeth (from 496 patients receiving warfarin, 2321 patients not receiving warfarin; mean age (SD): 62.2 (17.6)) extracted between 1 November 2008 and 31 March 2010, were collected. Warfarin-receiving patients were eligible when prothrombin time–international normalised ratio (PT-INR) measured within 7?days prior to the extraction was less than 3.0. Interventions Simple dental extraction was performed, and incidence of postextraction bleeding and comorbidities were recorded. Primary and secondary outcome measures Postextraction bleeding not controlled by basic haemostasis procedure was clinically significant. Results Bleeding events were reported for 35 (7.1%) and 49 (2.1%) teeth, of which 18 (3.6%) and 9 (0.4%) teeth were considered clinically significant, in warfarin and non-warfarin groups, respectively, the difference between which was 3.24% (CI 1.58% to 4.90%). The incidence rates by patients were 2.77% and 0.39%, in warfarin and non-warfarin groups, respectively (incidence difference 2.38%, CI 0.65% to 4/10%). Univariate analyses showed that age (OR 0.197, p=0.001), PT-INR (OR 3.635, p=0.003), mandibular foramen conduction anaesthesia (OR 4.854, p=0.050) and formation of abnormal granulation tissue in extraction socket (OR 2.900, p=0.031) significantly correlate with bleeding incidence. Multivariate analysis revealed that age (OR 0.126, p=0.001), antiplatelet drugs (OR 0.100, p=0.049), PT-INR (OR 7.797, p=0.001) and history of acute inflammation at extraction site (OR 3.722, p=0.037) were significant risk factors for postextraction bleeding. Conclusions Our results suggest that there is slight but significant increase in the incidences of postextraction bleeding in patients receiving warfarin. Although absolute incidence was low in both groups, the bleeding risk is not negligible.
机译:目的我们调查了接受华法林和未接受抗凝治疗的患者拔出后出血的发生率和危险因素。设计横断面,多中心,观察性研究。设置26家拥有口腔外科医师的医院。参与者收集了2008年11月1日至2010年3月31日提取的2817颗牙齿的数据(来自496例接受华法令的患者,2321例不接受华法令的患者;平均年龄(SD):62.2(17.6))。当提取前7天之内凝血酶原时间与国际标准化比率(PT-INR)小于3.0,则接受华法林的患者符合条件。干预措施进行简单的拔牙,并记录拔牙后出血和合并症的发生率。主要和次要结果指标不受基本止血程序控制的拔牙后出血具有临床意义。结果据报道,华法林和非华法林组分别有35(7.1%)和49(2.1%)颗牙齿发生出血事件,其中18颗(3.6%)和9颗(0.4%)牙齿被认为具有临床意义。其间为3.24%(CI为1.58%至4.90%)。华法林组和非华法林组患者的发生率分别为2.77%和0.39%(发生率差异2.38%,CI 0.65%至4/10%)。单因素分析显示年龄(OR 0.197,p = 0.001),PT-INR(OR 3.635,p = 0.003),下颌孔传导麻醉(OR 4.854,p = 0.050)和拔牙窝中异常肉芽组织的形成(OR 2.900) ,p = 0.031)与出血发生率显着相关。多变量分析显示年龄(OR 0.126,p = 0.001),抗血小板药物(OR 0.100,p = 0.049),PT-INR(OR 7.797,p = 0.001)和提取部位的急性炎症史(OR 3.722,p = 0.037)是拔牙后出血的重要危险因素。结论我们的结果表明接受华法林的患者拔出后出血的发生率略有但显着增加。尽管两组的绝对发生率均较低,但出血风险不可忽略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号